48 results on '"Pyo, Hong Ryull"'
Search Results
2. X-ray scattering effect on the heterogeneous dose distribution in a cell box
3. Dosimetric Verification of Dynamic Conformal Arc Radiotherapy using the Optimization Algorithm
4. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas: Ablative dose PBT for NSCLC
5. Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes
6. Predictive Value of 18F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
7. Simultaneous Integrated Boost Intensity-Modulated Radiotherapy in Patients With High-Grade Gliomas
8. A Phase II Study of Synchronous Three-Dimensional Conformal Boost to the Gross Tumor Volume for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: Results of Korean Radiation Oncology Group 0301 Study
9. Gastrointestinal Stromal Tumor of the Rectum: An Analysis of Seven Cases
10. Predictive Value of 18 F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer.
11. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy
12. Cyclooxygenase-2 Expression in Pretreatment Biopsy as a Predictor of Tumor Responses After Preoperative Chemoradiation in Rectal Cancer
13. Randomized Phase 2 Study of Subcutaneous Amifostine Versus Epoetin-α Given 3 Times Weekly During Concurrent Chemotherapy and Hyperfractionated Radiotherapy for Limited-Disease Small Cell Lung Cancer
14. Primary Chemotherapy for Newly Diagnosed Nonsmall Cell Lung Cancer Patients With Synchronous Brain Metastases Compared With Whole-Brain Radiotherapy Administered First: Result of A Randomized Pilot Study
15. Randomized phase 2 study of subcutaneous amifostine versus epoetin- given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer
16. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix
17. Initial Experience of Patient-Specific QA for Wobbling and Line-Scanning Proton Therapy at Samsung Medical Center
18. P2.02-044 Impact of N2 Extent and Nodal Response on Survival after Trimodal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer
19. MA06.03 Recurrence Dynamics after Trimodality Therapy (Neoadjuvant Chemoradiotherapy and Surgery) in Stage IIIa(N2) Lung Cancer
20. P2.05-023 Patterns of Failure after Adjuvant Radiation Therapy Based On “Tumor Bed with Margin” for Stage III Thymic Epithelial Tumor
21. The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center
22. Dosimetric Verification of Dynamic Conformal Arc Radiotherapy using the Optimization Algorithm
23. X-ray scattering effect on the heterogeneous dose distribution in a cell box
24. Radical prostatectomy versus external beam radiotherapy for localized prostate cancer
25. A phase II study of hypofractionated proton therapy for prostate cancer
26. Ablativ dosierte Protonentherapie bei Stadium-I- und rekurrierenden nichtkleinzelligen Lungenkarzinomen : Ablativ dosierte Protonentherapie für NSCLC.
27. High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer
28. The Expression of DNA Damage Checkpoint Proteins and Prognostic Implication in Metastatic Brain Tumors
29. Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
30. Inter- and Intrafractional Movement–Induced Dose Reduction of Prostate Target Volume in Proton Beam Treatment
31. SMART (Simultaneous Modulated Accelerated RadioTherapy) for locally advanced nasopharyngeal carcinomas
32. PD5-1-2: A phase I/II study of concurrent hypofractionated chemoradiotherapy using concomitant boost by 3D-conformal or intensity modulated radiotherapy for patients with stage III non-small cell lung cancer: preliminary results of Korean Radiation Oncology Group (KROG) Study- 0301
33. B2-05: Frontline cytotoxic chemotherapy (CTx) for newly diagnosed non-small cell lung cancer (NSCLC) patients presenting with brain metastasis compared to whole brain radiotherapy (WBRT): Result of a randomized pilot study
34. A new homogeneity index based on statistical analysis of the dose-volume histogram
35. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation
36. Effect of radiation scattering on dose uniformity in open and closed cell culture vessels
37. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose–volume parameters
38. Evaluation of Parotid Gland Function following Intensity Modulated Radiation Therapy for Head and Neck Cancer
39. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non–small-cell lung cancer
40. Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung Cancer
41. Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix
42. Radiation Treatment for Aggressive Fibromatosis: Findings from Observed Patterns of Local Failure
43. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy
44. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck
45. Neoadjuvant Chemotherapy and Radiation for Inoperable Carcinoma of the Maxillary Antrum
46. A phase I/II study of concurrent hypofractionated chemoradiotherapy using concomitant boost by 3D-conformal or intensity modulated radiotherapy for patients with stage III non-small cell lung cancer: preliminary results of Korean Radiation Oncology Group (KROG) Study- 0301
47. Frontline cytotoxic chemotherapy (CTx) for newly diagnosed non-small cell lung cancer (NSCLC) patients presenting with brain metastasis compared to whole brain radiotherapy (WBRT): Result of a randomized pilot study.
48. Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.